TELAPREVIR
| Brand name | INCIVEK |
|---|---|
| Active ingredient | TELAPREVIR |
| Strength | 375MG |
| Dosage form | TABLET |
| Route | ORAL |
| Modality | Small molecule |
| FDA approval | May 2011 |
| Marketing status | DISCN |
| Patent | Expires | Type |
|---|---|---|
| 8431615 | May 2028 | use U-1398 |
Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the latest FDA-listed patent expiry; estimates are projections, not legal advice.